MohamedESalamaMD

Pathology • Austin, TX

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Professor, Pathology, University of Utah School of Medicine

Join to view full profile

Dr. Salama is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Salama's full profile

Already have an account?

Office
12357 Riata Trace Pkwy
Ste A210
Austin, TX 78727
Phone+1 512-439-1600

Education & Training

University of New Mexico School of MedicineFellowship, Hematopathology, 2005 - 2006
Henry Ford Health/Henry Ford HospitalResidency, Pathology-Anatomic and Clinical, 2000 - 2004
Cairo University School of MedicineClass of 1994

Certifications & Licensure

CA State Medical License 2003 - 2026
TX State Medical License 2022 - 2026
UT State Medical License 2006 - 2026
MN State Medical License 2017 - 2024
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Hematopathology

Publications & Presentations

PubMed

118 citations
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Dmitriy Berenzon
Blood. 2019-10-31
361 citations
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu, Matthew R. Guthrie, Stefanie Böhm, Johannes Brägelmann, Ismail Can
Cancer Cell. 2017-02-13
9 citations
Machine learning and augmented human intelligence use in histomorphology for haematolymphoid disorders.
Ahmad Nanaa, Zeynettin Akkus, Winston Y Lee, Liron Pantanowitz, Mohamed E. Salama
Pathology. 2021-02-25

Abstracts/Posters

Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Set...
Mohamed E. Salama, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

National Evaluation System for Health Technology Coordinating Center Adds Clinical Laboratory and Patient Engagement Expertise to Governing CommitteeJuly 15th, 2021
ARUP Labs, ASI Enter Multi-Year CollaborationDecember 6th, 2016
Vision24: When Every Hour Counts. Leading the Revolution Within the LaboratorySeptember 26th, 2016